Bernstein Raises UnitedHealth Target Price, Expects EPS Recovery

Bernstein analysts have revised their target price for UnitedHealth Group upward, citing expectations of an earnings per share (EPS) recovery. The investment firm forecasts that the healthcare giant will see an improvement in its financial performance in the coming period. Analysts noted that UnitedHealth has a strong operational structure under current market conditions, which will support EPS growth. The new target price reflects positive signals in the company's profitability outlook. Bernstein's assessment is based on stable demand in UnitedHealth's health insurance and services segments, as well as its success in cost management. The firm believes these factors will enhance the company's earnings potential. This is not investment advice.